Bumrungrad applies rigorous quality control and adheres to internationally recognized standards.
We evaluate three key outcome indicators: in-hospital mortality and morbidity rates, timeliness of care, and patient safety.
Our results consistently exceed global benchmarks, reflecting the quality of care, the effectiveness of our multidisciplinary teams, and our commitment to delivering the best possible outcomes.
Bumrungrad’s mortality and morbidity rates are below the benchmark rates of the American Society of Anesthesiologists, ACC-NCDR, Singapore Data Registry, and GRACE.
We achieve these results through multidisciplinary teamwork, advanced treatment methods, state-of-the-art technologies, and rigorous monitoring and follow-ups. As a result, our key indicators — including pre-operative, post-operative, perioperative, maternal, and neonatal mortality rates — consistently perform better than international standards.
- Perioperative mortality rate: 0.1% (compared to the international standard: 2.1%)
- Direct Surgical mortality rate: 0.03% (compared to the international standard: 0.5%)
- In-hospital heart failure mortality rate: 0% (compared to the international standard: 5%)
- Stroke mortality rate: 5.8% (compared to the international standard: 7.4%)
- Acute myocardial infarction mortality rate: 3.6% (compared to the international standard: 7.5%)
- Postpartum mortality rate: 0% (compared to the international standard of 8 deaths per 100,000 live births)
- Neonatal mortality rate: 0% (compared to the international standard of 8 deaths per 10,000 live births)
Bumrungrad’s treatment initiation rates exceed international standards. When time is critical, rapid access to care is essential for survival and reducing disease severity.
We achieve this through seamless teamwork and well-established processes that efficiently connect each stage of care, from diagnosis to emergency response, treatment initiation, and critical radiology reporting, ensuring patients receive timely, coordinated care.
- Breast cancer diagnosis within 3 days: 100%
- Breast cancer treatment initiated within 7 days of diagnosis: 98%
“A safety rating higher than international standards.” Higher than the safety rates of the ACS QVP, AHRQ, CDC, and NDNQI.
Patient safety is a core priority at Bumrungrad International Hospital. We follow strict patient monitoring and assessment protocols to support accurate identification and help prevent potential risks during treatment.
Our commitment to high-quality care is reflected in key outcome indicators, 30-day hospital readmission rate, 30-day revision surgery rate, in-hospital venous thromboembolism rate, and hospital-acquired infection rates.
- Rate of Unplanned transfer to a higher level of care: 0.3% (compared to the international standard: 3.7%)
- Rate of 30-day hospital readmission: 0.42% (compared to the international standard: 3.4%)
- Rate of 30-day revision surgery: 0.35% (compared to the international standard: 2.8%)
- Rate of abdominal and pelvic symptoms due to accidental punctures and lacerations: 0.97% (compared to the international standard: 0.99%)
- Rate of urinary tract infections among patients with indwelling urinary catheters: 0.68% (compared to the international standard: 0.74%)
- Rate of central line-associated bloodstream infections (CLABSI): 0.18% (compared to the international standard: 0.72%)